fda approved glp 1 drugs GLP-1 Safety Check FDA Approves First Generic GLP-1
Description
The compound was dissolved in dry CH 2 Cl 2 under an N 2 atmosphere and reacted with 4-nitrophenyl chloroformate (1.2 equivalents) for 4 h

Nevertheless, the data sheets of several GLP-1 RAs do not recommend their administration to patients with severe gastrointestinal disease due to the limited experience in managing this condition
Risk of Retained Gastric Contents in Patients Using GLP-1RAs or Tirzepatide Presenting for Endoscopy or General Anesthesia Retrospective studies suggest that individuals on GLP-1-based therapy (exenatide, liraglutide, dulaglutide, semaglutide, or tirzepatide) appear to be at an increased risk of having retained gastric contents [Supplementary Table S3 (21)

One of the advantages Holst's group had in working on the issue was that researchers in Copenhagen were skilled at keeping pancreases alive that had been removed from pigs by perfusion with artificial blood
